ATB — Antibiotice SA Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual income statement for Antibiotice SA, fiscal year end - December 31st, RON millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	340	366	483	601	675
Cost of Revenue
Gross Profit	239	230	331	380	430
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	307	332	437	504	568
Operating Profit	33.7	34	45.7	96.5	107
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	28.3	30.3	41.9	91.5	103
Provision for Income Taxes
Net Income After Taxes	26.4	29.9	38.5	81.1	102
Net Income Before Extraordinary Items
Net Income	26.4	29.9	38.5	81.1	102
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	26.4	29.9	38.5	81.1	102
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.039	0.045	0.057	0.123	0.152
Dividends per Share